- Home
- AG vs ACLX Comparison
AG vs ACLX Comparison
Compare AG & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AG
- ACLX
- Stock Information
- Founded
- AG 1979
- ACLX 2015
- Country
- AG Canada
- ACLX United States
- Employees
- AG N/A
- ACLX N/A
- Industry
- AG Precious Metals
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- AG Basic Materials
- ACLX Health Care
- Exchange
- AG Nasdaq
- ACLX Nasdaq
- Market Cap
- AG 6.2B
- ACLX 4.4B
- IPO Year
- AG N/A
- ACLX 2022
- Fundamental
- Price
- AG $12.05
- ACLX $90.01
- Analyst Decision
- AG Strong Buy
- ACLX Strong Buy
- Analyst Count
- AG 3
- ACLX 8
- Target Price
- AG $14.25
- ACLX $115.50
- AVG Volume (30 Days)
- AG 16.9M
- ACLX 427.8K
- Earning Date
- AG 11-05-2025
- ACLX 11-05-2025
- Dividend Yield
- AG 0.17%
- ACLX N/A
- EPS Growth
- AG N/A
- ACLX N/A
- EPS
- AG 0.16
- ACLX N/A
- Revenue
- AG $965,571,000.00
- ACLX $35,898,000.00
- Revenue This Year
- AG $107.28
- ACLX N/A
- Revenue Next Year
- AG $18.07
- ACLX $220.95
- P/E Ratio
- AG $86.47
- ACLX N/A
- Revenue Growth
- AG 83.84
- ACLX N/A
- 52 Week Low
- AG $5.09
- ACLX $47.86
- 52 Week High
- AG $15.69
- ACLX $100.34
- Technical
- Relative Strength Index (RSI)
- AG 48.31
- ACLX 57.21
- Support Level
- AG $11.60
- ACLX $85.00
- Resistance Level
- AG $12.82
- ACLX $91.68
- Average True Range (ATR)
- AG 0.67
- ACLX 4.14
- MACD
- AG -0.06
- ACLX -0.08
- Stochastic Oscillator
- AG 63.26
- ACLX 71.76
About AG First Majestic Silver Corp. (Canada)
First Majestic Silver Corp is engaged in the production, development, exploration, and acquisition of mineral properties with a focus on silver and gold production in North America. It owns three producing mines in Mexico consisting of the San Dimas Silver/Gold Mine, the Santa Elena Silver/Gold Mine, and the La Encantada Silver Mine.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.